[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 574253, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 224597, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 393044, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 63, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 574335, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.96, "open": 0.97, "dayLow": 0.96, "dayHigh": 1.01, "regularMarketPreviousClose": 0.96, "regularMarketOpen": 0.97, "regularMarketDayLow": 0.96, "regularMarketDayHigh": 1.01, "payoutRatio": 0.0, "beta": 0.693, "forwardPE": -3.7547574, "volume": 174020, "regularMarketVolume": 174020, "averageVolume": 461600, "averageVolume10days": 352010, "averageDailyVolume10Day": 352010, "bid": 0.98, "ask": 1.03, "bidSize": 5, "askSize": 5, "marketCap": 111099352, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 1.59, "allTimeHigh": 10.0, "allTimeLow": 0.45, "fiftyDayAverage": 1.00368, "twoHundredDayAverage": 1.13832, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 75512744, "profitMargins": 0.0, "floatShares": 75497027, "sharesOutstanding": 111680087, "sharesShort": 1939850, "sharesShortPriorMonth": 2248846, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0194, "heldPercentInsiders": 0.03138, "heldPercentInstitutions": 0.19966, "shortRatio": 6.54, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 111680087, "bookValue": 0.07948389, "priceToBook": 12.515743, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -34784616, "trailingEps": -0.3, "forwardEps": -0.26494387, "enterpriseToEbitda": -2.074, "52WeekChange": -0.2992701, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 0.9948, "targetHighPrice": 9.192192, "targetLowPrice": 6.034066, "targetMeanPrice": 7.810147, "targetMedianPrice": 8.007164, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 11622408, "totalCashPerShare": 0.133, "ebitda": -36409240, "totalDebt": 134199, "quickRatio": 3.593, "currentRatio": 3.893, "debtToEquity": 1.404, "returnOnAssets": -1.48826, "returnOnEquity": -3.4798098, "freeCashflow": -15344989, "operatingCashflow": -24222644, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1770421222, "regularMarketTime": 1770411602, "regularMarketChangePercent": 3.625, "regularMarketPrice": 0.9948, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "ipoExpectedDate": "2021-08-10", "cryptoTradeable": false, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -1.4776835, "postMarketPrice": 0.9801, "postMarketChange": -0.0146999955, "regularMarketChange": 0.0348, "regularMarketDayRange": "0.96 - 1.01", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 461600, "fiftyTwoWeekLowChange": 0.22379994, "fiftyTwoWeekLowChangePercent": 0.2902723, "fiftyTwoWeekRange": "0.771 - 1.59", "fiftyTwoWeekHighChange": -0.59520006, "fiftyTwoWeekHighChangePercent": -0.37433964, "fiftyTwoWeekChangePercent": -29.92701, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.3, "epsForward": -0.26494387, "epsCurrentYear": -0.43, "priceEpsCurrentYear": -2.3134882, "fiftyDayAverageChange": -0.008880019, "fiftyDayAverageChangePercent": -0.00884746, "twoHundredDayAverageChange": -0.14352, "twoHundredDayAverageChangePercent": -0.12608054, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]